TRIAZOLONE COMPOUNDS AND USES THEREOF

The invention disclosed herein is directed to compounds of Formula I [Formula should be inserted here] and pharmaceutically acceptable salts thereof, which are useful in the treatment of prostate, breast, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The inventio...

Full description

Saved in:
Bibliographic Details
Main Authors BACCEI, JILL MELISSA, STOCK, NICHOLAS SIMON, CHEN, AUSTIN CHIH-YU, CLARK, RYAN CHRISTOPHER, STEARNS, BRIAN ANDREW, JACINTHO, JASON DUARTE, BRAVO, YALDA MOSTOFI
Format Patent
LanguageEnglish
French
Published 26.06.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention disclosed herein is directed to compounds of Formula I [Formula should be inserted here] and pharmaceutically acceptable salts thereof, which are useful in the treatment of prostate, breast, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention also comprises pharmaceutical compositions comprising a therapeutically effective amount of compound of Formula I, or a pharmaceutically acceptable salt thereof. The invention disclosed herein is also directed to methods of treating prostate, breast, ovarian, liver, kidney, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention disclosed herein is further directed to methods of treating prostate, breast, colon, pancreatic, chronic lymphocytic leukemia, melanoma and other cancers comprising administration of a therapeutically effective amount of a selective PPARa antagonist. The compounds and pharmaceutical compositions of the invention are also useful in the treatment of viral infections, such as HCV infections and HIV infections.
AbstractList The invention disclosed herein is directed to compounds of Formula I [Formula should be inserted here] and pharmaceutically acceptable salts thereof, which are useful in the treatment of prostate, breast, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention also comprises pharmaceutical compositions comprising a therapeutically effective amount of compound of Formula I, or a pharmaceutically acceptable salt thereof. The invention disclosed herein is also directed to methods of treating prostate, breast, ovarian, liver, kidney, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention disclosed herein is further directed to methods of treating prostate, breast, colon, pancreatic, chronic lymphocytic leukemia, melanoma and other cancers comprising administration of a therapeutically effective amount of a selective PPARa antagonist. The compounds and pharmaceutical compositions of the invention are also useful in the treatment of viral infections, such as HCV infections and HIV infections.
Author CHEN, AUSTIN CHIH-YU
BRAVO, YALDA MOSTOFI
CLARK, RYAN CHRISTOPHER
BACCEI, JILL MELISSA
JACINTHO, JASON DUARTE
STEARNS, BRIAN ANDREW
STOCK, NICHOLAS SIMON
Author_xml – fullname: BACCEI, JILL MELISSA
– fullname: STOCK, NICHOLAS SIMON
– fullname: CHEN, AUSTIN CHIH-YU
– fullname: CLARK, RYAN CHRISTOPHER
– fullname: STEARNS, BRIAN ANDREW
– fullname: JACINTHO, JASON DUARTE
– fullname: BRAVO, YALDA MOSTOFI
BookMark eNrjYmDJy89L5WRQDQnydIzy9_H3c1Vw9vcN8A_1cwlWcPRzUQgNdg1WCPFwDXL1d-NhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHOjkYWliZGFoaOhsZEKAEATogksw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate COMPOSES DE TRIAZOLONE ET LEURS UTILISATIONS
ExternalDocumentID CA2894281A1
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2894281A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:06:26 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2894281A13
Notes Application Number: CA20132894281
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140626&DB=EPODOC&CC=CA&NR=2894281A1
ParticipantIDs epo_espacenet_CA2894281A1
PublicationCentury 2000
PublicationDate 20140626
PublicationDateYYYYMMDD 2014-06-26
PublicationDate_xml – month: 06
  year: 2014
  text: 20140626
  day: 26
PublicationDecade 2010
PublicationYear 2014
RelatedCompanies INCEPTION 2, INC
RelatedCompanies_xml – name: INCEPTION 2, INC
Score 2.9319084
Snippet The invention disclosed herein is directed to compounds of Formula I [Formula should be inserted here] and pharmaceutically acceptable salts thereof, which are...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title TRIAZOLONE COMPOUNDS AND USES THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140626&DB=EPODOC&locale=&CC=CA&NR=2894281A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-L8Ig_at-K6td18KNIlKVVsU2orw5fRjxT2Moer-O97Dd30Rd9CAknu4PK7X3J3AbiZVMZYIk7o9-is6mZhl_pkJDN9UCA4ZJZRmipdLAhtPzWfZtasA4tNLoyqE_qliiOiRRVo77U6r1c_l1hMxVau7_IFdr0_eInDtJYdI1tAB11jU4dHggmqUepQVwtjB3kFOtqGi0Rpp_GimzL7_HXaJKWsfiOKdwi7EU62rI-gI5c92Kebj9d6sBe0793YbE1vfQy3SfzovolnEXJCRRCJNGQvxA0ZSfFIJInPYy68EyAeT6iv43rzrWxz6m53NjqFLlJ-eQakHBuFRHHyoWmZBUKGUVWZhfZXWdIe5Fkf-n9Oc_7P2AUcNEpqQp2G9iV0649PeYWgWufXSh3fvz52oQ
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401VhvWjW2vjgoN2JpedQDMXSBUAWWIJjGC-GxJL3UxmL8-w4bWr3obbOb7O5MMvvNtzszC3A7rWSdIU5ID-isSkqhldJ0wjJpVCA4ZKpcKjxdzA80N1GeFuqiA8ttLgyvE_rFiyOiRRVo7zU_r9c_l1gWj63c3OdL7Hp_dGLDElt2jGwBHXTRmhl2SC1KREIMYopBZCCvQEdbNpEo7elNcd7Gc3qdNUkp69-I4hzBfoiTrepj6LBVH3pk-_FaHw789r0bm63pbU7gLo7m5hv1aGALhPohTQLrRTADS0jwSBRi145s6pyC4NgxcSVcL93JlhJzt7PJGXSR8rNzEEpdLhiKk48VVSkQMuSqylS0v0pl2ijPBjD4c5rhP2M30HNj30u9efB8AYeNwpqwp7F2Cd3645NdIcDW-TVXzTdzKnmO
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TRIAZOLONE+COMPOUNDS+AND+USES+THEREOF&rft.inventor=BACCEI%2C+JILL+MELISSA&rft.inventor=STOCK%2C+NICHOLAS+SIMON&rft.inventor=CHEN%2C+AUSTIN+CHIH-YU&rft.inventor=CLARK%2C+RYAN+CHRISTOPHER&rft.inventor=STEARNS%2C+BRIAN+ANDREW&rft.inventor=JACINTHO%2C+JASON+DUARTE&rft.inventor=BRAVO%2C+YALDA+MOSTOFI&rft.date=2014-06-26&rft.externalDBID=A1&rft.externalDocID=CA2894281A1